Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladder

European Urology

Volumn 20, Issue 3, 1991, Pages 238-242

  Lipponen, P ^a   Eskelinen, M ^a   Syrjanen, S ^a   Tervahauta, A ^a   Syrjanen, K ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

AgNORs; Bladder cancer; C erb B 2 oncoprotein; Clinical stage; DNA ploidy; S phase fraction; WHO grade

Indexed keywords

ONCOPROTEIN;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CHROMOSOME NOR; DIPLOIDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

EID: 0026321254     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000471706     Document Type: Article

References (0)